Insider Trading & Executive Data
Start Free Trial
51 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
FVCBANKCORP INC (FVCB) is a Nasdaq‑listed, Fairfax, VA bank holding company whose sole subsidiary, FVCbank, serves small‑ and mid‑sized businesses, professional services, non‑profits, government contractors and retail customers in the Washington, D.C. and Baltimore MSAs. Core products are commercial lending (notably CRE, construction, government‑contract and SBA lending), consumer/residential loans, treasury services, digital banking and merchant services; total assets were ~$2.20B with loans of $1.87B and CRE representing ~64% of loans (and ~371% of total risk‑based capital) at year‑end 2024. Recent results show improved profitability driven by higher net interest income and margin (2024 NII $55.6M; NIM ~2.62%; Q2 2025 NIM ~2.90%), selective balance‑sheet actions (BOLI surrender, securities sales) and active liquidity management, while exposures of note include CRE concentration and sizable cannabis‑related deposits/loans disclosed in 2025.
Given FVCB’s regional‑bank model and small headcount, executive pay is likely a mix of base salary, annual cash incentives tied to near‑term financial metrics (net interest income, net interest margin, loan growth, fee income and expense control) and equity‑based awards (restricted stock or options) to retain key bankers. Management’s use of non‑GAAP “commercial bank operating earnings,” one‑time portfolio actions (BOLI surrender, securities sales) and capital management (buybacks of ~415k shares for $4.6M and a newly initiated $0.06 quarterly dividend) suggests incentive plans may exclude or adjust for discrete items—creating potential divergence between GAAP results and bonus payouts. Regulatory constraints and bank risk management (capital ratios, ACL methodology tied to peer PD/LGD, AML/OFAC compliance, CFPB scrutiny) will push for multi‑year payouts, deferrals and clawback provisions to align incentives with credit and liquidity outcomes, especially given CRE concentration and cannabis banking legal uncertainty.
Insider trades at FVCB should be interpreted in the context of a small float, concentrated local franchise and material event drivers (CRE stress, cannabis exposure, changes in funding mix, and periodic securities/BOLI actions) that can quickly alter perceived value. Look for insider purchases as stronger signals given the thin share base and management’s recent buybacks — buys near or after margin improvement (2024–Q2 2025) may indicate conviction in sustainable NII gains; routine sales may instead reflect liquidity needs or pre‑existing 10b5‑1 plans. Regulatory reporting, Section 16 filings, blackout windows around earnings and heightened supervisory scrutiny of incentive compensation mean insiders will often use planned trading schedules; sudden large sales prior to negative credit or regulatory announcements (CRE downgrades, cannabis‑related regulatory moves) can be particularly informative to traders and researchers.